These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 15209876)
21. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates. Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498 [TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells: a promising candidate in regenerative medicine. Chen Y; Shao JZ; Xiang LX; Dong XJ; Zhang GR Int J Biochem Cell Biol; 2008; 40(5):815-20. PubMed ID: 18295530 [TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Le Blanc K; Ringdén O Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957 [TBL] [Abstract][Full Text] [Related]
24. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design. Fan X; Liu T; Liu Y; Ma X; Cui Z Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963 [TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Li CD; Zhang WY; Li HL; Jiang XX; Zhang Y; Tang PH; Mao N Cell Res; 2005 Jul; 15(7):539-47. PubMed ID: 16045817 [TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Ramasamy R; Fazekasova H; Lam EW; Soeiro I; Lombardi G; Dazzi F Transplantation; 2007 Jan; 83(1):71-6. PubMed ID: 17220794 [TBL] [Abstract][Full Text] [Related]
27. Adult stem cells and advanced in vitro technology. Editorial. Fuhr GR Ann Anat; 2009 Jan; 191(1):1. PubMed ID: 19010647 [No Abstract] [Full Text] [Related]
28. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Le Blanc K; Ringdén O Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285 [TBL] [Abstract][Full Text] [Related]
29. Trafficking and differentiation of mesenchymal stem cells. Liu ZJ; Zhuge Y; Velazquez OC J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871 [TBL] [Abstract][Full Text] [Related]
30. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. Bertani N; Malatesta P; Volpi G; Sonego P; Perris R J Cell Sci; 2005 Sep; 118(Pt 17):3925-36. PubMed ID: 16091422 [TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells for tissue engineering and regenerative medicine. Tae SK; Lee SH; Park JS; Im GI Biomed Mater; 2006 Jun; 1(2):63-71. PubMed ID: 18460758 [TBL] [Abstract][Full Text] [Related]
32. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Mrugala D; Bony C; Neves N; Caillot L; Fabre S; Moukoko D; Jorgensen C; Noël D Ann Rheum Dis; 2008 Mar; 67(3):288-95. PubMed ID: 17644536 [TBL] [Abstract][Full Text] [Related]